World's first biopsy-driven RA trial finds tocilizumab superior to rituximab - Healio

World's first biopsy-driven RA trial finds tocilizumab superior to rituximab  Healio

Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network